The report was released by the US Food and Drug Administration. An eye lubricant used to induce artificial tears is being recalled from the market. It is a medicine used to treat dry eyes.
The drug was supplied by Delsum Pharma. There are also complaints that the medicine is leaking from the tube due to improper packaging of some medicines. Meanwhile, the presence of bacteria has also been found in tubes with safe packaging. Global Pharma had withdrawn the drug from the market on February 24, 2023. Use of contaminated medication can cause serious eye infections. It may even affect eyesight. It is in this situation that the drugs brought to the market are recalled.
Also Read: This CEO Is A Model; A dancer, the net worth is Rs 1,800 crore
Members from the Central and State Drug Regulatory Committees will inspect the manufacturing plant of Global Pharma Healthcare near Chennai, official sources said. It has also been clarified that the company does not sell this medicine in India. Apart from Delsum Pharma, Aru Pharma also distributes the drug. The company has informed wholesalers and retailers who have the recalled product not to supply the medicine. Consumers are advised not to use the medicine even if they are in possession of it. A new incident is being reported amid discussions regarding the quality of medicines manufactured in India and distributed to foreign countries as well.
The World Health Organization had earlier issued a warning against giving cough syrups made by Noida-based company Marion Biotech to children. The incident of children dying after consuming the cough syrup Doc-1 Max manufactured by Marion Biotech has led to many discussions. .Cough syrup was consumed by 21 children suffering from respiratory diseases. Uzbekistan stated that 18 children died. Similarly, in the African country of Gambia, it was recently alleged that the cough medicines of four Indian companies were responsible for the death of 66 children.
